HMGA1 and neoplasm: In line with the colony formation assays described above (Fig. 2G–J), HMGA1 deficiency resulted in an increased sensitivity of tumors to DDP treatment in vivo, as reflected by decreased tumor growth as well as by smaller tumor masses at the end point analysis (Fig. 7B–D), which were partially reversed by treatment with the ferroptosis inhibitor ferrostatin-1.